Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel ADPRHL2 gene mutation linked to newly identified neurological syndrome

May 5, 2020

Phase III data for HL-301 in acute bronchitis

May 5, 2020

GDC-9545, a third-generation ER-alpha ligand with improved potency

May 5, 2020

Allakos reports interim data from open-label extension study of antolimab

May 5, 2020

Shanghai Ennova Biopharmaceutical identifies new TRK inhibitors

May 5, 2020

Takeda Pharmaceutical synthesizes mTOR inhibitors

May 5, 2020

CytoDyn requests compassionate use of leronlimab for COVID-19

May 5, 2020

New SSTR5 agonists presented by Heptares Therapeutics

May 5, 2020

Intarcia Therapeutics discloses new amylin analogues

May 5, 2020

Viriom initiates phase II study of long-acting injectable VM-1500A

May 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...